tiprankstipranks

KemPharm appoint Christopher Posner to board of directors

KemPharm (KMPH) announced the appointment of Christopher Posner to serve on the Company’s Board of Directors. Posner is currently the president and CEO of Cara Therapeutics (CARA), a commercial-stage biopharmaceutical company.

Confident Investing Starts Here:

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on KMPH:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue